Medical News

ADT Increases the Risk of Other Cause Mortality in Elderly Patients with Localized Prostate Cancer

A recent retrospective study concluded that androgen deprivation therapy (ADT) for ≥2 years significantly increases the risk of mortality due to...

20 Mar, 2019

 
Email this page
BMD Changes and Factors Influencing Bone Loss in Breast Cancer Patients

Cancer treatment-induced bone loss (CTIBL) is one of themost prevalent long-term problems in breast cancer survivors however, its frequency, pattern...

01 Mar, 2019

 
Email this page
AA plus P Added to ADT Improves Clinical Outcomes in Patients with Metastatic Castration-Naïve Prostate Cancer

Event-driven medical resource utilization (MRU) data from the LATITUDE clinical trial was analysed in this study. The results showed that...

26 Feb, 2019

 
Email this page
Darolutamide Prolongs Metastasis-Free Survival without Increasing Adverse Events in Non-Metastatic Castration-Resistant Prostate Cancer

A randomized, double-blind, phase 3 trial evaluated the efficacy of darolutamide, a structurally unique androgen-receptor antagonist that is under...

25 Feb, 2019

 
Email this page

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

SWISH Trial: Dexamethasone Oral Solution Four Times a Day, Keeps Stomatitis Away

The SWISH trial investigated the prophylactic use of dexamethasone-based mouthwash for stomatitis in women receiving everolimus and exemestane for...

Early Use of Vacuum Therapy Has an Excellent Therapeutic Effect in Men undergoing Radical Prostatectomy

Early use of vacuum therapy significantly improved the erectile dysfunction and penile shrinkage in men post radical prostatectomy (RP) and enhanced...

Survival Outcomes with Extended and Limited Lymph Node Dissection in Bladder Cancer Patients undergoing Radical Cystectomy

A recent prospective study concluded that the extended lymph node dissection (LND) in bladder cancer patients undergoing radical cystectomy did not...

Enzalutamide and Abiraterone Improved Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer

Enzalutamide was the most effective in prolonging the progression-free survival,  followed by abiraterone and tasquinimod in patients with...

Infographics

Explore >>

Currently there is no content under this category.

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
43% (3 votes)
Tegafur uracil
0% (0 votes)
5-FU
57% (4 votes)
Total votes: 7